Intracranial Tumor Clinical Trial
Official title:
Application of 99mTc-CNDG SPECT/CT Imaging in the Diagnosis of Brain Tumors
The goal of this clinical trial is to evaluate the value of 99mTc-CNDG for diagnosis of brain tumors by comparing it with 18F-FDG-PET. The main questions it aims to answer are: 1. What is the diagnostic consistency between 99mTc-CNDG and 18F-FDG? 2. What is the correlation between the SUVmax value of 99mTc-CNDG and tumor type? Participants will: Receive18F-FDG-PET and 99mTc-CNDG examination within 2 weeks before surgery. Obtain pathological diagnosis by surgery or biopsy as the gold standard.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01674582 -
Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters
|
N/A | |
| Completed |
NCT00936806 -
Observational Study of the Differences in Characteristics of the Spontaneous Electroencephalogram, Derived From the Left and Right Hemisphere in Patients With Unilateral Intracranial Tumor During Routine Anesthesia: Comparison With a Control Group Without Intracranial Pathology
|
N/A | |
| Completed |
NCT03123302 -
Our Anesthesia Experience During MRI Scan
|
||
| Completed |
NCT04597801 -
Comparison of Fluorescein-INtra-VItal Microscopy Versus Conventional Frozen Section Diagnosis for intraOperative Histopathological Evaluation
|
Phase 2 |